I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Pat..:
Chow, Laura Q. M
;
Barlesi, Fabrice
;
Bertino, Erin M
...
Clinical Cancer Research, Vol.28 No.12, pp.2506-2516. , 2022
Link:
https://hdl.handle.net/10371/184627
RT Journal T1
ASCEND-7: Efficacy and Safety of Ceritinib Treatment in Patients with ALK-Positive Non-Small Cell Lung Cancer Metastatic to the Brain and/or Leptomeninges
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_184627&Exemplar=1&LAN=DE A1 Chow, Laura Q. M A1 Barlesi, Fabrice A1 Bertino, Erin M A1 van den Bent, Martin J A1 Wakelee, Heather A A1 Wen, Patrick Y A1 Chiu, Chao-Hua A1 Orlov, Sergey A1 Chiari, Rita A1 Majem, Margarita A1 McKeage, Mark A1 Yu, Chong-Jen A1 Garrido, Pilar A1 Hurtado, Felipe K A1 Arratia, Pilar Cazorla A1 Song, Yuanbo A1 Branle, Fabrice A1 Shi, Michael A1 Kim, Dong-Wan PB American Association for Cancer Research YR 2022 K1 TYROSINE KINASE INHIBITORS K1 OPEN-LABEL K1 CRIZOTINIB K1 CHEMOTHERAPY K1 SURVIVAL K1 MANAGEMENT K1 DIAGNOSIS K1 CARCINOMATOSIS K1 ALECTINIB K1 OUTCOMES JF Clinical Cancer Research, Vol.28 No.12, pp.2506-2516 LK http://dx.doi.org/https://hdl.handle.net/10371/184627 DO https://hdl.handle.net/10371/184627 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)